BR0203902A - Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma - Google Patents

Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma

Info

Publication number
BR0203902A
BR0203902A BR0203902-8A BR0203902A BR0203902A BR 0203902 A BR0203902 A BR 0203902A BR 0203902 A BR0203902 A BR 0203902A BR 0203902 A BR0203902 A BR 0203902A
Authority
BR
Brazil
Prior art keywords
cell
compositions
biochemical compounds
compounds involved
metabolism
Prior art date
Application number
BR0203902-8A
Other languages
English (en)
Inventor
Matthias Rath
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BR0203902A publication Critical patent/BR0203902A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/415—Cytochromes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSIçõES DE COMPOSTOS BIOQUìMICOS ENVOLVIDOS NO METABOLISMO BIOENERGéTICO DAS CéLULAS E MéTODO DE USO DA MESMA". Uma composição de compostos bioquímicos envolvidos no metabolismo da bioenergia das células e um método de uso na prevenção e na terapia de doenças.
BR0203902-8A 2001-02-14 2002-02-14 Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma BR0203902A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26882501P 2001-02-14 2001-02-14
PCT/EP2002/001545 WO2002064129A2 (en) 2001-02-14 2002-02-14 Compositions of biochemical compounds involved in bioenergy metabolism of cells

Publications (1)

Publication Number Publication Date
BR0203902A true BR0203902A (pt) 2003-01-28

Family

ID=23024645

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0203902-8A BR0203902A (pt) 2001-02-14 2002-02-14 Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma

Country Status (23)

Country Link
US (2) US7056950B2 (pt)
EP (1) EP1368017A2 (pt)
JP (1) JP2004518712A (pt)
KR (1) KR20020093906A (pt)
CN (1) CN1457255A (pt)
AU (1) AU2002250942B2 (pt)
BR (1) BR0203902A (pt)
CA (1) CA2401383A1 (pt)
CZ (1) CZ20023935A3 (pt)
EE (1) EE200200585A (pt)
HR (1) HRP20020702A2 (pt)
HU (1) HUP0302384A2 (pt)
IL (1) IL151411A0 (pt)
MX (1) MXPA02010149A (pt)
NO (1) NO20024536L (pt)
NZ (1) NZ528194A (pt)
PL (1) PL363392A1 (pt)
RU (1) RU2301665C2 (pt)
SK (1) SK11252003A3 (pt)
TR (1) TR200202175T1 (pt)
UA (1) UA76444C2 (pt)
WO (1) WO2002064129A2 (pt)
ZA (1) ZA200207100B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245612A1 (en) 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
ITMI20021366A1 (it) * 2002-06-21 2003-12-22 Dietetic S P A Composizioni nutraceutiche e integratori alimentari contenenti nadh
CA2526586C (en) * 2003-09-09 2010-03-16 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
US7271099B2 (en) * 2005-06-06 2007-09-18 Ffei Limited Forming a conductive pattern on a substrate
DE102005035917A1 (de) * 2005-07-28 2007-02-01 November Ag Verwendung von Isocitrat, Isocitronensäure oder einem Derivat davon zur Herstellung eines Medikaments
NL1030611C2 (nl) 2005-12-07 2007-06-08 Maasland Nv Inrichting voor het afgeven van vloeibaar voeder aan een dier en autonoom verplaatsbaar voertuig voor gebruik in een dergelijke inrichting.
EP2005949A1 (en) 2006-03-13 2008-12-24 Kaneka Corporation Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent
NL1034771C2 (nl) 2007-11-29 2009-06-02 Lely Patent Nv Onbemand autonoom voertuig voor het verplaatsen van voeder.
WO2008007728A1 (fr) * 2006-07-13 2008-01-17 Kaneka Corporation Préparation orale contenue dans une structure à membrane lipidique, et agent contre la fatigue comprenant une coenzyme comme ingrédient actif
EP2139467B1 (en) * 2007-02-08 2016-09-21 Biogen MA Inc. Neuroprotection in demyelinating diseases
EP2680006A1 (en) 2007-02-08 2014-01-01 Biogen Idec MA Inc. Treatment for Amyotrophic Lateral Sclerosis
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915397B1 (fr) 2007-04-27 2012-01-20 Vincience Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
FR2918893B1 (fr) * 2007-07-20 2012-10-19 Vincience Utilisation d'un principe actif issu du lin pour preparer une composition destinee a activer le cytochrome c
US8257753B2 (en) 2007-07-20 2012-09-04 Isp Investments Inc. Use of an active principle originating from flax in a composition intended to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions
NL1036081C (nl) 2008-10-16 2010-04-19 Lely Patent Nv Onbemand voertuig met beveiligingsinrichting.
KR100977638B1 (ko) 2009-06-29 2010-08-24 서울대학교산학협력단 독성분이 있는 배출가스 혼합체에 생존하면서 온실가스를 흡수한 수생식물의 포식자를 이용하는 온실가스 제거 및 바이오 에너지 제조 방법
US8344032B2 (en) * 2010-03-26 2013-01-01 Kevin Meehan Composition for enhancing athletic performance
US9271983B2 (en) 2010-03-26 2016-03-01 Bioadatp, Llc Composition for enhancing athletic performance
NL1037957C2 (nl) 2010-05-12 2011-11-15 Lely Patent Nv Voertuig voor het verplaatsen van voer.
NL2010499C2 (en) 2013-03-21 2014-09-24 Lely Patent Nv Vehicle for displacing feed lying on a floor in a sideward displacement direction.
CN103478632B (zh) * 2013-09-17 2014-09-17 江西宇骏生物工程有限公司 一种果蔬保健片及其制备方法
JP6129395B1 (ja) * 2016-10-29 2017-05-17 誠一 荒木 ミトコンドリア活性化に起因した血管内皮細胞保護回復用還元型ビタミンｂ２製剤
US20210346329A1 (en) * 2018-10-11 2021-11-11 Imbria Pharmaceuticals, Inc. Tca cycle intermediates and methods of use thereof
PH12022551124A1 (en) * 2020-01-01 2023-08-23 Celagenex Res India Pvt Ltd Synergistic nutritional compositions for enhancing atp efficiency

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100517A (ja) * 1983-11-08 1985-06-04 Eisai Co Ltd 放射線潰瘍治療剤および方法
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US4981687A (en) * 1988-07-29 1991-01-01 University Of Florida Compositions and methods for achieving improved physiological response to exercise
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
IT1262954B (it) 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
US5559152A (en) * 1992-07-06 1996-09-24 Komissarova; Irina A. Pharmaceutical composition having antiacoholic activity
US5328701A (en) 1992-09-10 1994-07-12 Peregrine Surgical Ltd. Tissue irrigation solution
EP0675725B1 (en) * 1992-12-23 2002-01-30 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
DE4341000A1 (de) 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
DE19520662A1 (de) * 1995-06-07 1996-12-12 Beiersdorf Ag Mittel zur Behandlung von Kopfschuppen und zur Behandlung der Haare
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
DE19533330A1 (de) * 1995-09-11 1997-03-13 Beiersdorf Ag Gegen Hautkrebs wirksame topische Zubereitungen
US6033689A (en) * 1997-02-14 2000-03-07 Milk Specialities Company Animal feed composition of soluble sugar and dicarboxylic acid
US5874471A (en) * 1997-02-27 1999-02-23 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
JPH10333335A (ja) 1997-05-28 1998-12-18 Ricoh Co Ltd レジストパターンの形成方法
US6537969B1 (en) * 1997-10-24 2003-03-25 John P. Blass Nutritional supplement for cerebral metabolic insufficiencies
US5904924A (en) 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
JP2000128784A (ja) * 1998-10-20 2000-05-09 Kuressendo Corporation:Kk 二日酔い症状
US20020150627A1 (en) * 2001-01-26 2002-10-17 Stout Jeffrey Ray Composition containing creatine and phosphorus

Also Published As

Publication number Publication date
EP1368017A2 (en) 2003-12-10
IL151411A0 (en) 2003-04-10
SK11252003A3 (sk) 2003-12-02
NZ528194A (en) 2006-08-31
CZ20023935A3 (cs) 2003-05-14
ZA200207100B (en) 2003-09-04
US7056950B2 (en) 2006-06-06
WO2002064129A3 (en) 2003-05-08
PL363392A1 (en) 2004-11-15
MXPA02010149A (es) 2004-08-19
US20020173546A1 (en) 2002-11-21
UA76444C2 (en) 2006-08-15
HRP20020702A2 (en) 2004-02-29
RU2003125179A (ru) 2005-01-20
NO20024536D0 (no) 2002-09-20
AU2002250942B2 (en) 2007-04-26
HUP0302384A2 (hu) 2003-10-28
TR200202175T1 (tr) 2003-10-21
US20060140925A1 (en) 2006-06-29
CN1457255A (zh) 2003-11-19
KR20020093906A (ko) 2002-12-16
JP2004518712A (ja) 2004-06-24
CA2401383A1 (en) 2002-08-22
WO2002064129A2 (en) 2002-08-22
EE200200585A (et) 2004-04-15
NO20024536L (no) 2002-09-20
RU2301665C2 (ru) 2007-06-27

Similar Documents

Publication Publication Date Title
BR0203902A (pt) Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma
BR9811818A (pt) Uso de um composto, composto, e, composição farmacêutica
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BR0111034A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
NO20003546L (no) Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
ES2188214T3 (es) Composicion antioxidante que comprende acetil l-carnitina y acido alfa-lipoico.
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
NO20065368L (no) Terapeutiske blandinger inneholdende minst et pyrrolobenzodiazepinderivat og fludarabin
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
BR0316532A (pt) Composições farmacêuticas compreendendo, um composto de droga básico, respectivamente um ácido, um tensoativo e um ácido solúvel em água fisiologicamente tolerável, respectivamente, uma base
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
BRPI0515645A (pt) métodos terapêuticos, composições, compostos e usos de compostos
BR0003987A (pt) Composição laxativa
BR0115518A (pt) Kit de repinotan
BR9803251A (pt) Agente de embranquecimento fluorescente
BR9813424A (pt) Composição adaptada para a produção de perda de peso em um paciente
MA28844B1 (fr) Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol
BR0012478A (pt) Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos
BRPI0612840A8 (pt) Composição de ração para prevenir ou tratar doença renal, métodos para prevenir ou tratar doença renal e para produzir uma composição de ração, kit, e, meio para comunicar informação ou instruções
FR2857263B1 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.